Seneste opdatering :
08/05/2024
Vasodilator   Alprostadil  
Injektion
Stabilitet i (vandige) opløsninger Stabilitet i blandinger Faktorer der påvirker stabiliteten Kompatibilitet Administrationsvej Bibliografi Pdf
   Kemisk struktur  

Handelsnavn   Handelsnavn     

Handel navne er vejledende og hjælpestoffer sammensætning kan være forskellig afhængigt af landet og laboratorier

Alfaprostin Ægypten
Alistint Marokko
Alpros Tyrkiet
Alprostadil Argentina, Canada, Chile, Ecuador, Malaysia, Marokko, Rumænien, Spanien, Tyrkiet, Tyskland, USA
Alprostapint Argentina, Colombia, Ecuador, Marokko, Ungarn, Østrig
Alprostar Italien
Aplicav Brasilien
Cardiobon Argentina, Marokko
Caverject Belgien, Brasilien, Canada, Danmark, Frankrig, Italien, Norge, Polen, Portugal, Schweiz, Slovenien, Spanien, Storbritanien, Sverige, Sydafrika, Tyrkiet, USA, Østrig
Edex Frankrig
Liple Japan
Minprog Tyskland, Østrig
Ostapint Marokko, Mexico
Palux Japan
Pridax Rumænien, Spanien, Tyskland, Østrig
Prolisina VR Argentina
Prostandin Japan
Prostavasin Iran, Italien, Luxemborg, Polen, Tyskland, Ungarn, Ægypten, Østrig
Prostin VR Australien, Belgien, Canada, Danmark, Finland, Grækenland, Holland, Iran, Italien, Luxemborg, Malaysia, Norge, Polen, Portugal, Saudi-Arabien, Schweiz, Storbritanien, Ungarn, USA, Venezuela
Prostine VR Frankrig
Vasaprostan Rumænien
Bibliografi   Injektion   Bibliografi : Alprostadil  
Type Offentliggørelse
1072 Journal Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1899 Journal Trissel LA, Zhang Y.
Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction.
Int J Pharm Compound 2004 ; 8, 3: 231-235.
2003 Journal Paul M, Razzouq N, Tixier G, Astier A.
Stability of prostaglandin E1 (PGE1) in aqueous solutions.
EJHP Science 2005 ; 2: 31-36.
2090 Journal Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
2150 Journal Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G.
Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine.
J Urology 1998 ; 160; 2: 551-555.
2151 Journal Gatti R, Gotti R, Cavrini V, Soli M, Bertaccini A, Carparelli F.
Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC).
Int J Pharm 1995 ; 115: 113-117.
3201 Journal Dice JE.
Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit.
J Pediatr Pharmacol Ther 2006 ; 11:233?6.
3448 Journal Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M.
Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.
Ann Pharm Fr 2013 ; 71, 5: 358-363.
3761 Bog Chavan E.
Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie.
Master en pharmacie - University of Geneva 2014
3961 Journal McCluskey S.V,Kirkham K,Munson J.M.
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers.
Int J Pharm Compound 2017 ; 21, 2: 150-153.
4069 Journal Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F.
Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns.
EJHP 2018 ; 25, e2
4389 Journal Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213
4491 Journal De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A.
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
Eur J Pedia 2020
4507 Journal Ross E, Salinas A, Petty K, Her C, Carpenter J.
Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing.
Am J Health-Syst Pharm 2020 ;77,23:1980-1985
4543 Journal Senarathna G, Strunk T, Petrovski M, Batty K.
Physical compatibility of pentoxifylline and intravenous medications.
Archives of Disease in Childhood 2018 ;104:292–295.
4570 Journal Greenhill K, Hornsby E, Gorman G.
Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients.
Pharmaceuticals 2019
4651 Journal De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A.
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
Eur J Pedia 2021 ;180,1169–1176.

  Mentions Légales